199 related articles for article (PubMed ID: 30092600)
41. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
42. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
Eberhardt W; Stamatis G; Stuschke M; Wilke H; Müller MR; Kolks S; Flasshove M; Schütte J; Stahl M; Schlenger L; Budach V; Greschuchna D; Stüben G; Teschler H; Sack H; Seeber S
Br J Cancer; 1999 Dec; 81(7):1206-12. PubMed ID: 10584883
[TBL] [Abstract][Full Text] [Related]
43. The role of pulmonary resection in small cell lung cancer.
Chandra V; Allen MS; Nichols FC; Deschamps C; Cassivi SD; Pairolero PC
Mayo Clin Proc; 2006 May; 81(5):619-24. PubMed ID: 16706259
[TBL] [Abstract][Full Text] [Related]
44. Trends in pneumonectomy for treatment of small-cell lung cancer.
Zhao J; Nguyen A; Ding L; David EA; Atay SM; Wightman SC; McFadden PM; Kim AW
Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):583-591. PubMed ID: 32878450
[TBL] [Abstract][Full Text] [Related]
45. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
46. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.
Granetzny A; Boseila A; Wagner W; Krukemeyer G; Vogt U; Hecker E; Koch OM; Klinke F
Eur J Cardiothorac Surg; 2006 Aug; 30(2):212-6. PubMed ID: 16829087
[TBL] [Abstract][Full Text] [Related]
47. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
48. Non-Small Cell Lung Cancer with Chest Wall Involvement: Integrated Treatment or Surgery Alone?
Chiappetta M; Nachira D; Congedo MT; Meacci E; Porziella V; Margaritora S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):299-305. PubMed ID: 29510431
[TBL] [Abstract][Full Text] [Related]
49. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
50. Extended surgical resection in stage III non-small cell lung cancer.
Hillinger S; Weder W
Front Radiat Ther Oncol; 2010; 42():115-121. PubMed ID: 19955797
[TBL] [Abstract][Full Text] [Related]
51. Chemoradiotherapy duration correlates with overall survival in limited disease SCLC patients with poor initial performance status who successfully completed multimodality treatment.
Manapov F; Klöcking S; Niyazi M; Belka C; Hildebrandt G; Fietkau R; Klautke G
Strahlenther Onkol; 2012 Jan; 188(1):29-34. PubMed ID: 22189436
[TBL] [Abstract][Full Text] [Related]
52. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
53. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
[TBL] [Abstract][Full Text] [Related]
54. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
55. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
56. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?
Mirimanoff RO
Chin Clin Oncol; 2015 Dec; 4(4):49. PubMed ID: 26730761
[TBL] [Abstract][Full Text] [Related]
59. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.
Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L
Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336
[TBL] [Abstract][Full Text] [Related]
60. Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
Sawada S; Suehisa H; Ueno T; Yamashita M
Asian J Surg; 2017 Apr; 40(2):95-99. PubMed ID: 26362070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
